Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Liabilities from Discontinued Operations (2020 - 2021)

Historic Liabilities from Discontinued Operations for Palisade Bio (PALI) over the last 2 years, with Q1 2021 value amounting to $219757.0.

  • Palisade Bio's Liabilities from Discontinued Operations changed N/A to $219757.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $219757.0, marking a year-over-year change of. This contributed to the annual value of $234344.0 for FY2020, which is N/A changed from last year.
  • Palisade Bio's Liabilities from Discontinued Operations amounted to $219757.0 in Q1 2021.
  • Palisade Bio's 5-year Liabilities from Discontinued Operations high stood at $325812.0 for Q3 2020, and its period low was $219757.0 during Q1 2021.